Links to Exploration step
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Cancer Prevention in HIV-Infected Populations</title><author><name sortKey="Goncalves, Priscila H" sort="Goncalves, Priscila H" uniqKey="Goncalves P" first="Priscila H." last="Goncalves">Priscila H. Goncalves</name><affiliation><nlm:aff id="A1">HIV & AIDS Malignancy Branch, National Cancer Institute; NIH, Bethesda, MD</nlm:aff></affiliation></author><author><name sortKey="Montezuma Rusca, Jairo M" sort="Montezuma Rusca, Jairo M" uniqKey="Montezuma Rusca J" first="Jairo M." last="Montezuma-Rusca">Jairo M. Montezuma-Rusca</name><affiliation><nlm:aff id="A2">Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases; NIH, Bethesda, MD</nlm:aff></affiliation></author><author><name sortKey="Yarchoan, Robert" sort="Yarchoan, Robert" uniqKey="Yarchoan R" first="Robert" last="Yarchoan">Robert Yarchoan</name><affiliation><nlm:aff id="A1">HIV & AIDS Malignancy Branch, National Cancer Institute; NIH, Bethesda, MD</nlm:aff></affiliation></author><author><name sortKey="Uldrick, Thomas S" sort="Uldrick, Thomas S" uniqKey="Uldrick T" first="Thomas S." last="Uldrick">Thomas S. Uldrick</name><affiliation><nlm:aff id="A1">HIV & AIDS Malignancy Branch, National Cancer Institute; NIH, Bethesda, MD</nlm:aff></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PMC</idno><idno type="pmid">26970136</idno><idno type="pmc">4789150</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4789150</idno><idno type="RBID">PMC:4789150</idno><idno type="doi">10.1053/j.seminoncol.2015.09.011</idno><date when="2015">2015</date><idno type="wicri:Area/Pmc/Corpus">001867</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">001867</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Cancer Prevention in HIV-Infected Populations</title><author><name sortKey="Goncalves, Priscila H" sort="Goncalves, Priscila H" uniqKey="Goncalves P" first="Priscila H." last="Goncalves">Priscila H. Goncalves</name><affiliation><nlm:aff id="A1">HIV & AIDS Malignancy Branch, National Cancer Institute; NIH, Bethesda, MD</nlm:aff></affiliation></author><author><name sortKey="Montezuma Rusca, Jairo M" sort="Montezuma Rusca, Jairo M" uniqKey="Montezuma Rusca J" first="Jairo M." last="Montezuma-Rusca">Jairo M. Montezuma-Rusca</name><affiliation><nlm:aff id="A2">Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases; NIH, Bethesda, MD</nlm:aff></affiliation></author><author><name sortKey="Yarchoan, Robert" sort="Yarchoan, Robert" uniqKey="Yarchoan R" first="Robert" last="Yarchoan">Robert Yarchoan</name><affiliation><nlm:aff id="A1">HIV & AIDS Malignancy Branch, National Cancer Institute; NIH, Bethesda, MD</nlm:aff></affiliation></author><author><name sortKey="Uldrick, Thomas S" sort="Uldrick, Thomas S" uniqKey="Uldrick T" first="Thomas S." last="Uldrick">Thomas S. Uldrick</name><affiliation><nlm:aff id="A1">HIV & AIDS Malignancy Branch, National Cancer Institute; NIH, Bethesda, MD</nlm:aff></affiliation></author></analytic><series><title level="j">Seminars in oncology</title><idno type="ISSN">0093-7754</idno><idno type="eISSN">1532-8708</idno><imprint><date when="2015">2015</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p id="P2">People living with human immunodeficiency virus (HIV) are living longer since the advent of effective combined antiretroviral therapy (cART). While cART substantially decreases the risk of developing some cancers, HIV-infected individuals remain at high risk for Kaposi sarcoma, lymphoma and several solid tumors. Currently HIV-infected patients represent an aging group, and malignancies have become a leading cause of morbidity and mortality. Tailored cancer-prevention strategies are needed for this population. In this review we describe the etiologic agents and pathogenesis of common malignancies in the setting of HIV, as well as current evidence for cancer prevention strategies and screening programs.</p></div></front></TEI><pmc article-type="research-article"><pmc-comment>The publisher of this article does not allow downloading of the full text in XML form.</pmc-comment>
<pmc-dir>properties manuscript</pmc-dir>
<front><journal-meta><journal-id journal-id-type="nlm-journal-id">0420432</journal-id><journal-id journal-id-type="pubmed-jr-id">7488</journal-id><journal-id journal-id-type="nlm-ta">Semin Oncol</journal-id><journal-id journal-id-type="iso-abbrev">Semin. Oncol.</journal-id><journal-title-group><journal-title>Seminars in oncology</journal-title></journal-title-group><issn pub-type="ppub">0093-7754</issn><issn pub-type="epub">1532-8708</issn></journal-meta><article-meta><article-id pub-id-type="pmid">26970136</article-id><article-id pub-id-type="pmc">4789150</article-id><article-id pub-id-type="doi">10.1053/j.seminoncol.2015.09.011</article-id><article-id pub-id-type="manuscript">NIHMS755874</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Cancer Prevention in HIV-Infected Populations</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Goncalves</surname><given-names>Priscila H.</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Montezuma-Rusca</surname><given-names>Jairo M.</given-names></name><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name><surname>Yarchoan</surname><given-names>Robert</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Uldrick</surname><given-names>Thomas S.</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib></contrib-group><aff id="A1"><label>1</label>HIV & AIDS Malignancy Branch, National Cancer Institute; NIH, Bethesda, MD</aff><aff id="A2"><label>2</label>Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases; NIH, Bethesda, MD</aff><author-notes><corresp id="FN1">Corresponding Author: Thomas Uldrick, M.D., M.S., 10 Center Drive, Room 6N-106, MSC 1868, Bethesda, MD 20892, Phone: 301-402-6296, FAX: 301-480-5955, <email>uldrickts@mail.nih.gov</email></corresp></author-notes><pub-date pub-type="nihms-submitted"><day>3</day><month>2</month><year>2016</year></pub-date><pub-date pub-type="epub"><day>08</day><month>9</month><year>2015</year></pub-date><pub-date pub-type="ppub"><month>2</month><year>2016</year></pub-date><pub-date pub-type="pmc-release"><day>01</day><month>2</month><year>2017</year></pub-date><volume>43</volume><issue>1</issue><fpage>173</fpage><lpage>188</lpage><pmc-comment>elocation-id from pubmed: 10.1053/j.seminoncol.2015.09.011</pmc-comment>
<abstract><p id="P2">People living with human immunodeficiency virus (HIV) are living longer since the advent of effective combined antiretroviral therapy (cART). While cART substantially decreases the risk of developing some cancers, HIV-infected individuals remain at high risk for Kaposi sarcoma, lymphoma and several solid tumors. Currently HIV-infected patients represent an aging group, and malignancies have become a leading cause of morbidity and mortality. Tailored cancer-prevention strategies are needed for this population. In this review we describe the etiologic agents and pathogenesis of common malignancies in the setting of HIV, as well as current evidence for cancer prevention strategies and screening programs.</p></abstract></article-meta></front></pmc></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaSubSaharaV1/Data/Pmc/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 0018678 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd -nk 0018678 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= SidaSubSaharaV1
|flux= Pmc
|étape= Corpus
|type= RBID
|clé=
|texte=
}}
| This area was generated with Dilib version V0.6.32. |  |